Initial posttreatment versus subsequent follow-up
Combined Primary and Nodes | Posttreatment | Follow-Up |
---|---|---|
NI-RADS 1 | 5.7% (5/88) | 3.4% (15/440) |
NI-RADS 2 | 20.0% (4/20) | 15.8% (6/38) |
NI-RADS 3 | 50.0% (4/8) | 62.5% (15/24) |
Combined, all categories | 11.2% (13/116) | 7.2% (36/502) |